IV therapy or intravenous therapy is a medical process that specially delivers liquid or required fluid to the patient’s body through passing it directly through vein. The intravenous administration route is very commonly used for solutions like rehydration or also to offer any kind of nutrition in patients who cannot consume water or food through mouth easily and have difficulty in consumption. This could also be used to deliver the medications or other medical therapy like blood electrolytes or products to treat the imbalances in electrolyte. Efforts and attempts have also been made to offer intravenous therapy, but the practice failed to become widespread and effective as well until the development of techniques for effective and safer use.
IV Equipment market is estimated to be around US$ 10.0 Bn in 2017. It is anticipated to grow at a CAGR of 5.8% from 2019 to 2030.
Increasing geriatric population coupled with growing number of surgical procedures has been pivotal in dictating the growth of the IV equipment market. Moreover, Increasing patient awareness, rising prevalence of chronic diseases and increasing expenditures on healthcare is anticipated to be the major drive the growth of the global IV equipment market between 2019 and 2030. Christe University, along with Christie Medical Holdings, Inc. entered into collaborative agreement with B Braun Medical in 2017, to improve peripheral IV access success. Collaborations and partnerships of such forms is anticipated to further contribute to the growth of the IV equipment market, by promoting new innovative techniques of administering medications and other substances with greater efficiency through the intravenous routes.
Major Key Players of the IV Equipment Market are:
BD, B. Braun Melsungen AG, Baxter, Fresenius SE & Co. KGaA, ICU Medical, Inc., Smith Medical (Smiths Group plc.), TERUMO CORPORATION, MOOG INC., AngioDynamics, and Medline Industries, Inc.
No comments:
Post a Comment